AMA
Szymanska E, Dadalski M, Grajkowska W, Szymanska S, Pronicki M, Kierkus J. Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2017;12(1):44-48. doi:10.5114/pg.2016.64746.
APA
Szymanska, E., Dadalski, M., Grajkowska, W., Szymanska, S., Pronicki, M., & Kierkus, J. (2017). Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 12(1), 44-48. https://doi.org/10.5114/pg.2016.64746
Chicago
Szymanska, Edyta, Maciej Dadalski, Wieslawa Grajkowska, Sylwia Szymanska, Maciej Pronicki, and Jaroslaw Kierkus. 2017. "Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease". Gastroenterology Review/Przegląd Gastroenterologiczny 12 (1): 44-48. doi:10.5114/pg.2016.64746.
Harvard
Szymanska, E., Dadalski, M., Grajkowska, W., Szymanska, S., Pronicki, M., and Kierkus, J. (2017). Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 12(1), pp.44-48. https://doi.org/10.5114/pg.2016.64746
MLA
Szymanska, Edyta et al. "Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 12, no. 1, 2017, pp. 44-48. doi:10.5114/pg.2016.64746.
Vancouver
Szymanska E, Dadalski M, Grajkowska W, Szymanska S, Pronicki M, Kierkus J. Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2017;12(1):44-48. doi:10.5114/pg.2016.64746.
